United Therapeutics Corporation (UTHR)

Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$554.73-0.78%As of 2026-11-22 · USD
Last session low $551.76Last session high $563.11
52-week low $455.6352-week high $614.23
Market cap
$23.63B
Sector
Healthcare
P/E (TTM)
20.9x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)42.1In the neutral range (30 to 70)
MACD (12, 26, 9)4.01Below its signal line (9.93); histogram -5.92
Bollinger %B (20, 2)-4%Below the lower band (557.01 to 614.10)
SMA 20585.56Price is 5.3% below
SMA 50550.01Price is 0.9% above
SMA 200539.85Price is 2.8% above
ATR (20)3.23% of priceAverage true range per day
52-week position62%In the middle of the 455.63 to 614.23 range

About United Therapeutics Corporation

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Insider filings, 90 daysNo purchases and 64 sales (about $313.9M).
Latest fiscal yearEnded 2025-12-31: revenue of $3.18B and an operating margin of 47.7%.

More in Drug Manufacturers - Specialty & Generic